Kidney transplantation during coronavirus 2019 pandemic at a large hospital in Miami.

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Aditya ChandorkarJacques Simkins

Abstract

Coronavirus 2019 (COVID-19) pandemic has resulted in more than 350 000 deaths worldwide. The number of kidney transplants has declined during the pandemic. We describe our deceased donor kidney transplantation (DDKT) experience during the pandemic. A retrospective study was conducted to evaluate the safety of DDKT during the COVID-19 pandemic. Multiple preventive measures were implemented. Adult patients that underwent DDKT from 3/1/20 to 4/30/20 were included. COVID-19 clinical manifestations from donors and recipients, and post-transplant outcomes (COVID-19 infections, readmissions, allograft rejection, and mortality) were obtained. The kidney transplant (KT) recipients were followed until 5/31/20. Seventy-six patients received kidneys from 57 donors. Fever, dyspnea, and cough were reported in 1, 2, and 1 donor, respectively. Thirty-eight (66.6%) donors were tested for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) prior to donation (mainly by nasopharyngeal or bronchoalveolar lavage polymerase chain reaction [PCR]) and 36 (47.3%) KT recipients were tested at the time of DDKT by nasopharyngeal PCR; all of these were negative. Our recipients were followed for a median of 63 (range: 33-91) days. A total of 42 (55.3...Continue Reading

References

Jul 14, 2010·The Lancet Infectious Diseases·Deepali KumarUNKNOWN American Society of Transplantation H1N1 Collaborative Study Group
Jul 28, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E CorderoUNKNOWN Novel influenza A(H1N1) Study Group of Spanish Network for Research in Infectious Diseases (REIPI)
Sep 3, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M TonelliJ Gill
Mar 1, 2019·Clinical Transplantation·Oriol ManuelUNKNOWN American Society of Transplantation Infectious Diseases Community of Practice
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 28, 2020·Emerging Microbes & Infections·Weilie ChenXiaoping Tang
Apr 25, 2020·The New England Journal of Medicine·Enver AkalinMilan Kinkhabwala
Apr 26, 2020·Journal of Clinical Microbiology·Wei ZhenGregory J Berry
Apr 29, 2020·Emerging Microbes & Infections·Jing SunYi-Min Li
Jun 12, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N Thao N GalvanJohn A Goss
Jun 21, 2020·Journal of the American Society of Nephrology : JASN·Richard W CorbettUNKNOWN West London Renal and Transplant Centre

❮ Previous
Next ❯

Citations

Feb 19, 2021·Journal of Medical Internet Research·Alaa Abd-AlrazaqZubair Shah
May 20, 2021·American Journal of Physiology. Gastrointestinal and Liver Physiology·Emile LevySchohraya Spahis
Aug 7, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nattawat KlomjitMariam Priya Alexander
Oct 1, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Sumit MohanJesse D Schold

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
bronchoalveolar
biopsy
biopsies

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.